Encompass Health (NYSE:EHC) Stock Price Expected to Rise, UBS Group Analyst Says

Encompass Health (NYSE:EHC - Get Free Report) had its price objective increased by UBS Group from $117.00 to $130.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has a "buy" rating on the stock. UBS Group's price objective would indicate a potential upside of 12.70% from the company's previous close.

Several other equities research analysts have also issued reports on the stock. KeyCorp increased their target price on shares of Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a research note on Friday. William Blair reissued an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Barclays upped their target price on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research note on Friday. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research note on Friday. Finally, Royal Bank of Canada upped their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday. Nine analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Encompass Health has a consensus rating of "Buy" and a consensus target price of $120.86.

Encompass Health Stock Performance

EHC traded up $1.98 during midday trading on Monday, hitting $115.35. 1,228,258 shares of the company were exchanged, compared to its average volume of 677,912. The firm has a market capitalization of $11.62 billion, a price-to-earnings ratio of 25.86, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. The company's 50 day simple moving average is $100.08 and its 200 day simple moving average is $98.57. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. Encompass Health has a 1-year low of $82.38 and a 1-year high of $115.83.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The business's quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.12 EPS. As a group, sell-side analysts predict that Encompass Health will post 4.8 earnings per share for the current year.

Insiders Place Their Bets

In other news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Encompass Health

Institutional investors have recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB raised its position in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after buying an additional 137 shares during the period. Colonial Trust Co SC purchased a new stake in Encompass Health in the fourth quarter valued at $29,000. Transce3nd LLC acquired a new position in shares of Encompass Health in the 4th quarter valued at $40,000. CBIZ Investment Advisory Services LLC increased its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares during the last quarter. Finally, Tompkins Financial Corp acquired a new stake in shares of Encompass Health during the 4th quarter worth about $46,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.